Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Isogai

Showing results (81-90 of 85) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 85 results.
Journal of the National Cancer Institute|August 12, 2009
Prospective cost-effectiveness analysis of cetuximab in metastatic colorectal cancer: evaluation of National Cancer Institute of Canada Clinical Trials Group CO.17 trialNicole Mittmann, Heather-Jane Au, Dongsheng Tu, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|November 5, 1997
[Clinical efficacy of post-TUR prophylactic chemotherapy for superficial bladder cancer--the result of co-operative prospective randomized trial]Y Takahashi, M Kuriyama, S Yamada, et al.
Nihon Shokakibyo Gakkai Zasshi = the Japanese Journal of Gastro-Enterology|January 22, 1998
[Regional difference in the etiology of liver cirrhosis in Iwate]T Yoshida, T Katsurashima, K Abe, et al.
Journal of Inherited Metabolic Disease|September 10, 2005
Heparan sulfate levels in mucopolysaccharidoses and mucolipidosesS Tomatsu, M A Gutierrez, T Ishimaru, et al.
Journal of Inherited Metabolic Disease|May 7, 2005
Keratan sulphate levels in mucopolysaccharidoses and mucolipidosesS Tomatsu, K Okamura, H Maeda, et al.
Pageof 9

Showing results (81-90 of 85) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 85 results.
Journal of the National Cancer Institute|August 12, 2009
Prospective cost-effectiveness analysis of cetuximab in metastatic colorectal cancer: evaluation of National Cancer Institute of Canada Clinical Trials Group CO.17 trialNicole Mittmann, Heather-Jane Au, Dongsheng Tu, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|November 5, 1997
[Clinical efficacy of post-TUR prophylactic chemotherapy for superficial bladder cancer--the result of co-operative prospective randomized trial]Y Takahashi, M Kuriyama, S Yamada, et al.
Nihon Shokakibyo Gakkai Zasshi = the Japanese Journal of Gastro-Enterology|January 22, 1998
[Regional difference in the etiology of liver cirrhosis in Iwate]T Yoshida, T Katsurashima, K Abe, et al.
Journal of Inherited Metabolic Disease|September 10, 2005
Heparan sulfate levels in mucopolysaccharidoses and mucolipidosesS Tomatsu, M A Gutierrez, T Ishimaru, et al.
Journal of Inherited Metabolic Disease|May 7, 2005
Keratan sulphate levels in mucopolysaccharidoses and mucolipidosesS Tomatsu, K Okamura, H Maeda, et al.
Pageof 9